MIR22HG is demonstrated as a tumor suppressor through TGF-β/SMAD signaling in colorectal cancer, whose depletion can promote EMT process and tumor metastasis (Xu et al., 2020). The gene discussed is TGFB1; the disease is colorectal cancer.